The Traderszone Network

Published in TZ Latest News 11 November, 2017 by The TZ Newswire Staff

Argos Therapeutics Provides Update on Immunology Data from the Phase 3 ADAPT Trial Presented at the SITC 2017 Annual Meeting

DURHAM, N.C., Nov. 11, 2017 (GLOBE NEWSWIRE) — Argos Therapeutics, Inc.

read more